Gümligen, Switzerland

André Haeberli

This inventor holds 1 USPTO granted patent. Top assignee: Asulab S.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: André Haeberli. Retrieved from https://idiyas.com/inventor/andrandeacute-haeberli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of André Haeberli

Introduction

André Haeberli is a notable inventor based in Gümligen, Switzerland. He has made significant contributions to the field of medical technology, particularly in the area of blood coagulation.

Latest Patents

Haeberli holds a patent for an "Electrochemical system for determining blood coagulation time." This innovative system is designed to enhance the accuracy and efficiency of blood coagulation testing, which is crucial for various medical applications.

Career Highlights

André Haeberli is associated with Asulab S.A., a company that focuses on developing advanced medical technologies. His work at Asulab has allowed him to contribute to important advancements in healthcare.

Collaborations

Haeberli has collaborated with talented professionals such as Erik Jan Frenkel and Anita Moresi. These partnerships have fostered a creative environment that encourages innovation and the development of new technologies.

Conclusion

André Haeberli's contributions to medical technology, particularly through his patent and work at Asulab, highlight his role as an influential inventor in the field. His dedication to improving healthcare through innovation is commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…